BIOMARKER-POSITIVE APOE4 CARRIERS WITH MCI SHOW DISEASE STABILITY OVER 4-YEARS OF VALILTRAMIPROSATE/ALZ-801 TREATMENT: MMSE RESPONDER ANALYSIS FROM THE ALZ-801 PHASE 2 LONG-TERM EXTENSION STUDY

valiltramiprosate (ALZ-801) - Alzheon

https://cslide.ctimeetingtech.com/adpd26/attendee/eposter/poster/2119?r=d%7E1%7E%7Er%7E7

Patrick Kesslak1; Susan Abushakra1; Katerina Sheardova2; Jakub Hort3; Niels Prins4; Margaret Bray1; Adem Albayrak1; Aidan Power1; Martin Tolar1; John Hey1

Jan 10, 2026